Literature DB >> 21171877

Pathogenesis of arenavirus hemorrhagic fevers.

Marie-Laurence Moraz1, Stefan Kunz.   

Abstract

Viral hemorrhagic fevers (VHFs) caused by arenaviruses belong to the most devastating emerging human diseases and represent serious public health problems. Arenavirus VHFs in humans are acute diseases characterized by fever and, in severe cases, different degrees of hemorrhages associated with a shock syndrome in the terminal stage. Over the past years, much has been learned about the pathogenesis of arenaviruses at the cellular level, in particular their ability to subvert the host cell's innate antiviral defenses. Clinical studies and novel animal models have provided important new information about the interaction of hemorrhagic arenaviruses with the host's adaptive immune system, in particular virus-induced immunosuppression, and have provided the first hints towards an understanding of the terminal hemorrhagic shock syndrome. The scope of this article is to review our current knowledge on arenavirus VHF pathogenesis with an emphasis on recent developments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21171877     DOI: 10.1586/eri.10.142

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  38 in total

1.  Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro.

Authors:  Melissa W Hayes; Ricardo Carrion; Jerritt Nunneley; Andrei E Medvedev; Maria S Salvato; Igor S Lukashevich
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

3.  Arenavirus Coinfections Are Common in Snakes with Boid Inclusion Body Disease.

Authors:  J Hepojoki; P Salmenperä; T Sironen; U Hetzel; Y Korzyukov; A Kipar; O Vapalahti
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

4.  NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry.

Authors:  Matthijs Raaben; Lucas T Jae; Andrew S Herbert; Ana I Kuehne; Sarah H Stubbs; Yi-Ying Chou; Vincent A Blomen; Tomas Kirchhausen; John M Dye; Thijn R Brummelkamp; Sean P Whelan
Journal:  Cell Host Microbe       Date:  2017-11-08       Impact factor: 21.023

5.  Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.

Authors:  Brian B Gowen; Eric J Sefing; Jonna B Westover; Donald F Smee; Joseph Hagloch; Yousuke Furuta; Jeffery O Hall
Journal:  Antiviral Res       Date:  2015-07-14       Impact factor: 5.970

6.  Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus description.

Authors:  Guo-Yun Yu; Suzanne Mate; Karla Garcia; Michael D Ward; Ernst Brueggemann; Matthew Hall; Tara Kenny; Mariano Sanchez-Lockhart; Marie-Paule Lefranc; Gustavo Palacios
Journal:  Immunogenetics       Date:  2016-05-27       Impact factor: 2.846

Review 7.  Progress in the experimental therapy of severe arenaviral infections.

Authors:  Brian B Gowen; Mike Bray
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

8.  Replication of boid inclusion body disease-associated arenaviruses is temperature sensitive in both boid and mammalian cells.

Authors:  Jussi Hepojoki; Anja Kipar; Yegor Korzyukov; Lesley Bell-Sakyi; Olli Vapalahti; Udo Hetzel
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

9.  Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model.

Authors:  Marco A Goicochea; Juan C Zapata; Joseph Bryant; Harry Davis; Maria S Salvato; Igor S Lukashevich
Journal:  Vaccine       Date:  2012-01-09       Impact factor: 3.641

Review 10.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.